1-6 of 6
tacrolimus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Clinical Trials & Observations
Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2650–2659.
https://doi.org/10.1182/bloodadvances.2021004192
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021
Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Clinical Trials & Observations
Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4474–4482.
https://doi.org/10.1182/bloodadvances.2020001627
Published: 2020
Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Clinical Trials & Observations
Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3894–3899.
https://doi.org/10.1182/bloodadvances.2020002236
Published: 2020
Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3669–3676.
https://doi.org/10.1182/bloodadvances.2020001958
Published: 2020
Includes: Supplemental data
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data